NVision Quantum Technologies

NVision Quantum Technologies is a German deep-tech startup founded in 2015 and based in Ulm.

The company specializes in quantum technologies for healthcare, focusing on quantum-enhanced sensing for real-time metabolic imaging and photonic quantum computing for drug design. NVision has developed unique capabilities in quantum spin control in organic molecules, which power its two main platforms: POLARIS, a quantum-enhanced MRI system, and PIQC, a molecular photonic quantum computing platform. POLARIS utilizes parahydrogen-induced polarization to significantly enhance MRI signals, allowing for real-time monitoring of cancer therapy responses. PIQC employs organic molecule qubits to facilitate drug design and therapy validation. Targeting the healthcare sector, NVision aims to improve cancer diagnosis and treatment monitoring, making advanced metabolic imaging accessible to MRI clinics. The company has raised significant funding, including a $55 million Series B round, and partners with major investors like Abbott, enhancing its position in the medical diagnostics field.